Voogd AC - Search Results

1

Predicting the extent of nodal involvement for node positive breast cancer patients: Development and validation of a novel tool.

van den Hoven I, van Klaveren D, Verheuvel NC, van la Parra RFD, Voogd AC, de Roos WK, Bosscha K, Heuts EM, Tjan-Heijnen VCG, Roumen RMH, Steyerberg EW. van den Hoven I, et al. Among authors: voogd ac. J Surg Oncol. 2019 Sep;120(4):578-586. doi: 10.1002/jso.25644. Epub 2019 Jul 23. J Surg Oncol. 2019. PMID: 31338839 Free PMC article.

2

Comparison of breast-conserving therapy with mastectomy for treatment of early breast cancer in community hospitals.

Voogd AC, Nab HW, Crommelin MA, van der Heijden LH, Kluck HM, Coebergh JW. Voogd AC, et al. Eur J Surg Oncol. 1996 Feb;22(1):13-6. doi: 10.1016/s0748-7983(96)91220-2. Eur J Surg Oncol. 1996. PMID: 8846859 Free article. Clinical Trial.

3

Changing attitudes towards breast-conserving treatment of early breast cancer in the south-eastern Netherlands: results of a survey among surgeons and a registry-based analysis of patterns of care.

Voogd AC, Repelaer van Driel OJ, Roumen RM, Crommelin MA, van Beek MW, Coebergh JW. Voogd AC, et al. Eur J Surg Oncol. 1997 Apr;23(2):134-8. doi: 10.1016/s0748-7983(97)80006-6. Eur J Surg Oncol. 1997. PMID: 9158187

4

The risk of nodal metastases in breast cancer patients with clinically negative lymph nodes: a population-based analysis.

Voogd AC, Coebergh JW, Repelaer van Driel OJ, Roumen RM, van Beek MW, Vreugdenhil A, Crommelin MA. Voogd AC, et al. Breast Cancer Res Treat. 2000 Jul;62(1):63-9. doi: 10.1023/a:1006447825160. Breast Cancer Res Treat. 2000. PMID: 10989986

5

Detection, treatment and outcome of axillary recurrence after axillary clearance for invasive breast cancer.

de Boer R, Hillen HF, Roumen RM, Rutten HJ, van der Sangen MJ, Voogd AC. de Boer R, et al. Among authors: voogd ac. Br J Surg. 2001 Jan;88(1):118-22. doi: 10.1046/j.1365-2168.2001.01637.x. Br J Surg. 2001. PMID: 11136323

6

Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer.

Ververs JM, Roumen RM, Vingerhoets AJ, Vreugdenhil G, Coebergh JW, Crommelin MA, Luiten EJ, Repelaer van Driel OJ, Schijven M, Wissing JC, Voogd AC. Ververs JM, et al. Among authors: voogd ac. Eur J Cancer. 2001 May;37(8):991-9. doi: 10.1016/s0959-8049(01)00067-3. Eur J Cancer. 2001. PMID: 11334724

7

Determinants of axillary recurrence after axillary lymph node dissection for invasive breast cancer.

Voogd AC, de Boer R, van der Sangen MJ, Roumen RM, Rutten HJ, Coebergh JW. Voogd AC, et al. Eur J Surg Oncol. 2001 Apr;27(3):250-5. doi: 10.1053/ejso.2000.1111. Eur J Surg Oncol. 2001. PMID: 11373100

8

Early and late morbidity associated with axillary levels I-III dissection in breast cancer.

Ernst MF, Voogd AC, Balder W, Klinkenbijl JH, Roukema JA. Ernst MF, et al. Among authors: voogd ac. J Surg Oncol. 2002 Mar;79(3):151-5; discussion 156. doi: 10.1002/jso.10061. J Surg Oncol. 2002. PMID: 11870664

9

Lymphoedema and reduced shoulder function as indicators of quality of life after axillary lymph node dissection for invasive breast cancer.

Voogd AC, Ververs JM, Vingerhoets AJ, Roumen RM, Coebergh JW, Crommelin MA. Voogd AC, et al. Br J Surg. 2003 Jan;90(1):76-81. doi: 10.1002/bjs.4010. Br J Surg. 2003. PMID: 12520579

10

Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy.

Schijven MP, Vingerhoets AJ, Rutten HJ, Nieuwenhuijzen GA, Roumen RM, van Bussel ME, Voogd AC. Schijven MP, et al. Among authors: voogd ac. Eur J Surg Oncol. 2003 May;29(4):341-50. doi: 10.1053/ejso.2002.1385. Eur J Surg Oncol. 2003. PMID: 12711287

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

297 results

Search Page

Filters